Login / Signup
Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model.
Yanlin Wu
Guilian Zhang
Panpan Yin
Jinlin Wen
Ying Su
Xinyan Zhang
Published in:
Archives of oral biology (2024)
Brusatol improves anti-PD-1 antibody efficacy by targeting PD-L1, suggesting its potential as an adjuvant in anti-PD-1 immunotherapy.
Keyphrases
</>
poor prognosis
signaling pathway
long non coding rna